article thumbnail

GW Pharmaceuticals Pre-Announces Preliminary Unaudited Fourth Quarter and Full-Year 2019 Net Product Sales

Cannabis Law Report

12, 2020 (GLOBE NEWSWIRE) — GW Pharmaceuticals plc (Nasdaq: GWPH), the world leader in the science, development, and commercialization of cannabinoid prescription medicines, today reported preliminary, unaudited net product sales for the fourth quarter and full-year 2019 and key priorities for 2020. 14th at 11:00 a.m. PT (2:00 p.m.

article thumbnail

Understanding the Current Legal Status of Psychedelics in the United States

Cannabis Law Report

The only psychedelic drug that is approved (outside of clinical trials) for psychiatric use—as opposed to anesthesia—through the traditional medical system is Ketamine. On March 5, 2019, the U.S. For obvious reasons, religious exemptions from the CSA do not present compelling opportunities for entrepreneurs. Schedule I.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Medicinal cannabis users in the UK could be unfairly criminalised as study finds failures in roadside drug testing

Cannabis Law Report

The double-blind, randomised, placebo-controlled clinical trial took place over two years between 2017 and 2019 at the Center for Medicinal Cannabis Research at the University of California. medical cannabis users at risk of unfair prosecution, according to a report by Volteface.

article thumbnail

CBD Science Update

Project CBD

Over 200 scientists from around the world attended the four-day conference, which included 65 oral presentations and nearly 200 posters covering a wide range of topics – with the caveat that researchers had to present new, unpiblished data. THC was present in 89 percent of the samples, but in most cases no amount of THC was provided.

CBD 218
article thumbnail

What is CBN (Cannabinol)? How does the natural byproduct of THC work?

The Cannigma

Therefore, it makes sense that CBN is most commonly found in aged or improperly stored cannabis, and hardly ever present in fresh flower or low-temp extractions. In a 2019 animal study, CBN isolate was reported to relieve musculoskeletal pain. What can the current clinical trials tell us?

THC 140
article thumbnail

CBD Science Update

Project CBD

Just over 500 participants from around the world attended the four-day conference, which included 65 oral presentations and nearly 200 posters covering a wide range of topics – with the caveat that researchers had to present new, unpublished data. Related story Can CBD Help Your Condition? Preclinical promise.

CBD 177
article thumbnail

Cannabis Helps, Say Over Half of Parkinson’s Patients Who Use It

The Cannigma

In 2019, Parkinson’s UK announced the launch of a major £1.2 million clinical trial investigating the effects of CBD on hallucinations and delusions related to the disease. Still, research is ongoing. The post Cannabis Helps, Say Over Half of Parkinson’s Patients Who Use It appeared first on The Cannigma.